Drug Approval | December 19, 2022
Sun Pharmaceutical receives warning letter from USFDA for Halol facility
The Halol facility was placed under Import Alert by USFDA.
The Halol facility was placed under Import Alert by USFDA.
AUR101, with a good ADME/PK profile and high bioavailability, has demonstrated inhibition of IL-17A in whole blood from psoriasis patients
The designation recognizes Seeq's expertise in enabling faster insights and better business outcomes for life sciences customers, including Bristol Myers Squibb, with advanced analytics innovations.
This partnership stemmed from a successful customer-supplier relationship spanning several years.
Ayúdame3D has become a leading social entity in social technology.
The patent also covers the efficacy of the herbal composition in the management of metabolic syndrome disorders
To focus on providing safer burn treatments for women and armed forces
The current ruling will assure the safety of the use of Ranitidine for Indian patients
Implants from the U.S. startup Allay Therapeutics are designed to relieve pain after knee surgery for up to three weeks
EC grants conditional marketing authorization based on the EFFISAYIL trial
Subscribe To Our Newsletter & Stay Updated
